Tiziana Life Sciences Ltd
For the period ended Oct 16, 2026. Filed Oct 16, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Oct 16, 2026 · Filed Oct 16, 2026
Use the contents to explore the available documents and sections.
TLSA$0.69+11.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Segment reporting
Segment reporting
Operating segments are reported in a manner consistent with the internal reporting provided to the Board. The Board considers there to be only one operating segment being the research and development of biotechnological and pharmaceutical products.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.